by John Moore | January 21, 2021
In our latest Hot Take, Founder and Managing Director John Moore Jr. sits with us to share his thoughts on what this recent mega-merger means for each of the companies as well as what it portends for the industry. Transcript (mostly generated by AI - please excuse typos): [00:00:00] Hello,
by Alex Lennox-Miller | January 13, 2021
John Moore III: [00:00:23] Today, we'll be joined by Alex Lennox-Miller, one of the senior analysts here at Chilmark Research. His current focus is on virtual care and we'll be discussing exactly how the recent announcements from the Centers for Medicare and Medicaid Services will impact the adoption and the
by John Moore III | January 05, 2021
Below you will find the reports, articles and webinars that fostered the greatest engagement from the community over the last twelve months, grouped by type of content. Did you have any particular highlights from the last year you'd like to share? Drop it (them?) in the comments! Top Chilmark Research
by Chilmark Team | December 18, 2020
Unlike past years when we have written a post evaluating how well our predictions for that year held up, let’s just say the COVID pandemic threw a monkey wrench into everything and move on. Fortune-telling tools on wooden table That being said, before I started pulling these predictions for 2021
by Chilmark Team | December 01, 2020
John Moore, Alex Lennox-Miller, Jody Ranck, Brian Murphy Roughly a year ago, athenahealth held its first analyst event. This event came on the heels of athenahealth’s protracted battle with an activist investor that ultimately took the company private and led to the exit of their flamboyant CEO, Jonathan Bush. That first
by Chilmark Team | October 21, 2020
John Moore, Alex Lennox-Miller, Jody Ranck Virtual portal to the CHC event Last week, Cerner held part one of its two-part Cerner Health Conference (CHC). While we miss the opportunity to attend these meetings in person as it is far more insightful - thanks COVID – we did walk away
by Jody Ranck | October 15, 2020
While COVID-19 has been dominating the healthcare headlines so far in 2020 there have been a number of recent policy and regulatory decisions bearing on the AI/ML market in healthcare. We have been reading quite a bit about the broader slowdown in the market for AI/ML developers since the pandemic
by Alex Lennox-Miller | October 13, 2020
Salesforce is betting EHRs cannot improve quickly enough to meet user-experience needs of industry. The Salesforce Healthcare and Life Sciences summit was a shot across the bow for EHRs. There was no mistaking the content of the presentations, the message of their tools and deployments, or the explicit questions focused
